Skip to main content

Abstract

Today’s healthcare environment in the USA is rife with talk of the “value” of care in both the public and private spheres. Understanding this dynamic is central to understanding the role return on investment (ROI) plays in the evaluation of the merit and success of quality improvement initiatives. This chapter explores the concept of value in the larger sense and begins to discuss the details of how we will consider and operationalize the financial return of quality improvement activities. We will also cover the main challenges of conducting a ROI analysis in the healthcare setting and discuss the differences between prospective and retrospective analyses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    More information on programs like the Quality Payment Program (QPP), the Merit-based Incentive Payment System (MIPS), and the Alternative Payment Model (APM) approach can be found at https://qpp.cms.gov/about/qpp-overview.

  2. 2.

    This is not totally accurate: Most payers have agreements with providers so that the price charged to hospitals or clinics is lower than what would be charged to an individual paying out of pocket, as you have no doubt seen if you have ever examined a medical bill closely.

  3. 3.

    Not to mention that there may be value to the patient in performing the test simply to rule out certain conditions or maladies, even if the course of treatment would not be altered by the test result.

  4. 4.

    Such as in Measuring ROI in Healthcare by Victor Buzachero, Jack Phillips, Patricia Pulliam Phillips, and Zack Phillips. McGraw Hill. 2013.

References

  1. United States Congress (2010) The patient protection and affordable care act. Available at http://www.ncsl.org/documents/health/ppaca-consolidated.pdf

  2. CMS Innovation Center (2019) Innovation models. https://innovation.cms.gov/initiatives/#views=models. Accessed 17 Dec 2019

  3. CMS Innovation Center (2019) Medicare advantage value-based insurance design model. https://innovation.cms.gov/initiatives/vbid/. Accessed 17 Dec 2019

  4. Kaiser Family Foundation (2019) A dozen facts about medicare advantage in 2019. https://www.kff.org/medicare/issue-brief/a-dozen-facts-about-medicare-advantage-in-2019/. Accessed 17 Dec 2019

  5. Bresnick J (2018) 47% of payer, provider business tied to value-based care. https://healthpayerintelligence.com/news/47-of-payer-provider-business-tied-to-value-based-care. Accessed 17 Dec 2019

  6. Health Care Transformation Task Force (2017) 2017 transformation progress report. https://hcttf.org/2017-member-transformation-progress-report/. Accessed 17 Dec 2019

  7. Masterson L (2018) Payers moving to value-based care faster than expected. https://www.healthcaredive.com/news/payers-moving-to-value-based-care-faster-than-expected/525900/. Accessed 17 Dec 2019

  8. UnitedHealthCare (2019) Welcome to value-based care. https://www.uhc.com/valuebasedcare. Accessed 17 Dec 2019

  9. Cigna (2019) Moving from volume to value. https://www.cigna.com/about-us/newsroom/innovation/moving-from-volume-to-value-based-health-care. Accessed 17 Dec 2019

  10. Antonanzas F, Terkola R, Postma M (2016) The value of medicines: a crucial but vague concept. PharmacoEconomics 34(12):1227–1239. https://doi.org/10.1007/s40273-016-0434-8

    Article  PubMed  Google Scholar 

  11. Callahan CM, Boustani MA, Unverzagt FW, Austrom MG, Damush TM, Perkins AJ, Fultz BA, Hui SL, Counsell SR, Hendrie HC (2006) Effectiveness of collaborative care for older adults with alzheimer disease in primary care: a randomized controlled trial. JAMA 295(18):2148–2157. https://doi.org/10.1001/jama.295.18.2148

    Article  CAS  PubMed  Google Scholar 

  12. Vickrey BG, Mittman BS, Connor KI, Pearson ML, Della Penna RD, Ganiats TG, Demonte RW Jr, Chodosh J, Cui X, Vassar S, Duan N, Lee M (2006) The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial. Ann Intern Med 145(10):713–726. https://doi.org/10.7326/0003-4819-145-10-200611210-00004

    Article  PubMed  Google Scholar 

  13. Boustani M, Alder CA, Solid CA, Reuben D (2019) An alternative payment model to support widespread use of collaborative dementia care models. Health Aff 38(1):54–59. https://doi.org/10.1377/hlthaff.2018.05154

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Craig A. Solid .

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Solid, C.A. (2020). Introduction. In: Return on Investment for Healthcare Quality Improvement. Springer, Cham. https://doi.org/10.1007/978-3-030-46478-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-46478-3_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-46477-6

  • Online ISBN: 978-3-030-46478-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics